The intravenous fluid transfer drug devices market size has grown strongly in recent years. It will grow from $7.85 billion in 2025 to $8.35 billion in 2026 at a compound annual growth rate (CAGR) of 6.3%. The growth in the historic period can be attributed to reliance on conventional iv sets, increasing hospital and clinical procedures, limited availability of smart infusion devices, growing awareness of iv therapy benefits, adoption of pvc infusion bags.
The intravenous fluid transfer drug devices market size is expected to see strong growth in the next few years. It will grow to $10.55 billion in 2030 at a compound annual growth rate (CAGR) of 6%. The growth in the forecast period can be attributed to technological advancements in smart infusion pumps, rising demand for pre-filled and multi-chamber infusion bags, increasing applications in oncology and neurology, growth in home healthcare and ambulatory infusion, stricter regulatory and quality standards. Major trends in the forecast period include rising adoption of smart infusion devices and pumps, increasing use of pre-filled and multi-chamber infusion bags, growing demand for needleless connectors and safety iv sets, expansion of iv therapy across chronic and critical care treatments, enhanced focus on sterility, accuracy, and flow control.
The rising hospitalization rate is increasingly supporting the expansion of the intravenous fluid transfer drug device market going forward. Higher hospitalization rates are associated with aging populations, chronic diseases, improved diagnostic capabilities, broader healthcare access, and lifestyle-related health conditions. Intravenous fluid transfer drug devices ensure accurate and controlled delivery of fluids and medications directly into the bloodstream of hospitalized patients, supporting effective treatment and patient safety. For example, in March 2023, according to GOV.UK, a UK-based government organization, COVID-19 hospital admission rates in England increased slightly to 10.62 per 100,000 in 2023, while ICU and HDU admissions remained low. Consequently, rising hospitalization rates are reinforcing growth across the intravenous fluid transfer drug device market.
Leading companies in the intravenous fluid transfer drug device market are developing modular and comprehensive infusion systems with features such as auto-identification to improve accuracy, enhance patient safety, and streamline fluid and medication administration. Auto-identification technology automatically verifies and matches medications to the correct patient using barcode scanning or RFID systems. For example, in July 2023, Becton, Dickinson, and Company, a US-based medical device company, received FDA 510(k) clearance for its updated BD Alaris Infusion System. The system includes upgraded hardware for the Point-of-Care Unit, covering large-volume pumps, syringe pumps, patient-controlled analgesia pumps, respiratory monitoring, and auto-identification modules. It also introduces advanced software with improved cybersecurity and interoperability, allowing seamless integration with electronic medical record systems and supporting connected healthcare delivery.
In May 2024, Nordson Corporation, a US-based precision technology company, acquired Atrion Corporation for an undisclosed amount. Through this acquisition, Nordson Corporation aims to expand and strengthen its medical portfolio by integrating Atrion’s advanced infusion and cardiovascular technologies. Atrion Corporation is a US-based technology company specializing in components and devices for intravenous fluid transfer and drug delivery.
Major companies operating in the intravenous fluid transfer drug devices market are Cardinal Health Inc., Medtronic plc, Becton Dickinson and Company, Baxter International Inc., B Braun Holding GmbH Co KG, Fresenius Kabi AG, Nipro Corporation, West Pharmaceutical Services Inc., ICU Medical Inc., Merit Medical Systems Inc., Vygon SAS, AngioDynamics Inc., Elcam Medical Inc., InfuSystem Holdings Inc., CODAN US Corporation, Arcomed AG, Terumo Corporation, Smiths Medical, IRadimed Corporation, Micrel Medical Devices SA, Boston Scientific Corporation, AdvaCare Pharma, Eitan Medical, Ypsomed Holding AG.
North America was the largest region in the intravenous fluid transfer drug devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the intravenous fluid transfer drug devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the intravenous fluid transfer drug devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the intravenous fluid transfer drug devices market by increasing costs for imported infusion bags, smart infusion pumps, and needleless connectors. Segments such as multi-chamber infusion bags and smart infusion devices are most affected, particularly in Asia-Pacific regions including China and India. The tariffs have led to higher production costs and supply chain disruptions. On the positive side, they are encouraging local manufacturing, material innovation, and investment in domestic production capabilities, which may enhance long-term market resilience.
The intravenous fluid transfer drug devices market research report is one of a series of new reports that provides intravenous fluid transfer drug devices market statistics, including intravenous fluid transfer drug devices industry global market size, regional shares, competitors with a intravenous fluid transfer drug devices market share, detailed intravenous fluid transfer drug devices market segments, market trends and opportunities, and any further data you may need to thrive in the intravenous fluid transfer drug devices industry. This intravenous fluid transfer drug devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Intravenous fluid transfer drug devices deliver medications and fluids directly into the bloodstream through an IV line while maintaining sterility and preventing contamination, supporting efficient and controlled treatment in critical care settings.
The main product categories in the intravenous fluid transfer drug devices market include infusion bags, infusion devices, and others. Infusion bags are flexible, sterile containers designed to store and deliver fluids, medications, or nutrients directly into a patient’s bloodstream through an intravenous (IV) line. The applications include autoimmune disorders, blood-related conditions, cardiovascular disorders, neurological conditions, oncology treatments, and others, and the end users include hospitals, specialized clinics, and others.
The intravenous fluid transfer drug devices market consists of sales of infusion pumps, IV bags, tubing sets, connectors, catheters, needles, flow regulators, and syringes. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The intravenous fluid transfer drug devices market size is expected to see strong growth in the next few years. It will grow to $10.55 billion in 2030 at a compound annual growth rate (CAGR) of 6%. The growth in the forecast period can be attributed to technological advancements in smart infusion pumps, rising demand for pre-filled and multi-chamber infusion bags, increasing applications in oncology and neurology, growth in home healthcare and ambulatory infusion, stricter regulatory and quality standards. Major trends in the forecast period include rising adoption of smart infusion devices and pumps, increasing use of pre-filled and multi-chamber infusion bags, growing demand for needleless connectors and safety iv sets, expansion of iv therapy across chronic and critical care treatments, enhanced focus on sterility, accuracy, and flow control.
The rising hospitalization rate is increasingly supporting the expansion of the intravenous fluid transfer drug device market going forward. Higher hospitalization rates are associated with aging populations, chronic diseases, improved diagnostic capabilities, broader healthcare access, and lifestyle-related health conditions. Intravenous fluid transfer drug devices ensure accurate and controlled delivery of fluids and medications directly into the bloodstream of hospitalized patients, supporting effective treatment and patient safety. For example, in March 2023, according to GOV.UK, a UK-based government organization, COVID-19 hospital admission rates in England increased slightly to 10.62 per 100,000 in 2023, while ICU and HDU admissions remained low. Consequently, rising hospitalization rates are reinforcing growth across the intravenous fluid transfer drug device market.
Leading companies in the intravenous fluid transfer drug device market are developing modular and comprehensive infusion systems with features such as auto-identification to improve accuracy, enhance patient safety, and streamline fluid and medication administration. Auto-identification technology automatically verifies and matches medications to the correct patient using barcode scanning or RFID systems. For example, in July 2023, Becton, Dickinson, and Company, a US-based medical device company, received FDA 510(k) clearance for its updated BD Alaris Infusion System. The system includes upgraded hardware for the Point-of-Care Unit, covering large-volume pumps, syringe pumps, patient-controlled analgesia pumps, respiratory monitoring, and auto-identification modules. It also introduces advanced software with improved cybersecurity and interoperability, allowing seamless integration with electronic medical record systems and supporting connected healthcare delivery.
In May 2024, Nordson Corporation, a US-based precision technology company, acquired Atrion Corporation for an undisclosed amount. Through this acquisition, Nordson Corporation aims to expand and strengthen its medical portfolio by integrating Atrion’s advanced infusion and cardiovascular technologies. Atrion Corporation is a US-based technology company specializing in components and devices for intravenous fluid transfer and drug delivery.
Major companies operating in the intravenous fluid transfer drug devices market are Cardinal Health Inc., Medtronic plc, Becton Dickinson and Company, Baxter International Inc., B Braun Holding GmbH Co KG, Fresenius Kabi AG, Nipro Corporation, West Pharmaceutical Services Inc., ICU Medical Inc., Merit Medical Systems Inc., Vygon SAS, AngioDynamics Inc., Elcam Medical Inc., InfuSystem Holdings Inc., CODAN US Corporation, Arcomed AG, Terumo Corporation, Smiths Medical, IRadimed Corporation, Micrel Medical Devices SA, Boston Scientific Corporation, AdvaCare Pharma, Eitan Medical, Ypsomed Holding AG.
North America was the largest region in the intravenous fluid transfer drug devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the intravenous fluid transfer drug devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the intravenous fluid transfer drug devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the intravenous fluid transfer drug devices market by increasing costs for imported infusion bags, smart infusion pumps, and needleless connectors. Segments such as multi-chamber infusion bags and smart infusion devices are most affected, particularly in Asia-Pacific regions including China and India. The tariffs have led to higher production costs and supply chain disruptions. On the positive side, they are encouraging local manufacturing, material innovation, and investment in domestic production capabilities, which may enhance long-term market resilience.
The intravenous fluid transfer drug devices market research report is one of a series of new reports that provides intravenous fluid transfer drug devices market statistics, including intravenous fluid transfer drug devices industry global market size, regional shares, competitors with a intravenous fluid transfer drug devices market share, detailed intravenous fluid transfer drug devices market segments, market trends and opportunities, and any further data you may need to thrive in the intravenous fluid transfer drug devices industry. This intravenous fluid transfer drug devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Intravenous fluid transfer drug devices deliver medications and fluids directly into the bloodstream through an IV line while maintaining sterility and preventing contamination, supporting efficient and controlled treatment in critical care settings.
The main product categories in the intravenous fluid transfer drug devices market include infusion bags, infusion devices, and others. Infusion bags are flexible, sterile containers designed to store and deliver fluids, medications, or nutrients directly into a patient’s bloodstream through an intravenous (IV) line. The applications include autoimmune disorders, blood-related conditions, cardiovascular disorders, neurological conditions, oncology treatments, and others, and the end users include hospitals, specialized clinics, and others.
The intravenous fluid transfer drug devices market consists of sales of infusion pumps, IV bags, tubing sets, connectors, catheters, needles, flow regulators, and syringes. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Intravenous Fluid Transfer Drug Devices Market Characteristics
3. Intravenous Fluid Transfer Drug Devices Market Supply Chain Analysis
4. Global Intravenous Fluid Transfer Drug Devices Market Trends and Strategies
5. Intravenous Fluid Transfer Drug Devices Market Analysis of End Use Industries
7. Global Intravenous Fluid Transfer Drug Devices Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Intravenous Fluid Transfer Drug Devices Total Addressable Market (TAM) Analysis for the Market
9. Intravenous Fluid Transfer Drug Devices Market Segmentation
10. Intravenous Fluid Transfer Drug Devices Market Regional and Country Analysis
11. Asia-Pacific Intravenous Fluid Transfer Drug Devices Market
12. China Intravenous Fluid Transfer Drug Devices Market
13. India Intravenous Fluid Transfer Drug Devices Market
14. Japan Intravenous Fluid Transfer Drug Devices Market
15. Australia Intravenous Fluid Transfer Drug Devices Market
16. Indonesia Intravenous Fluid Transfer Drug Devices Market
17. South Korea Intravenous Fluid Transfer Drug Devices Market
18. Taiwan Intravenous Fluid Transfer Drug Devices Market
19. South East Asia Intravenous Fluid Transfer Drug Devices Market
20. Western Europe Intravenous Fluid Transfer Drug Devices Market
21. UK Intravenous Fluid Transfer Drug Devices Market
22. Germany Intravenous Fluid Transfer Drug Devices Market
23. France Intravenous Fluid Transfer Drug Devices Market
24. Italy Intravenous Fluid Transfer Drug Devices Market
25. Spain Intravenous Fluid Transfer Drug Devices Market
26. Eastern Europe Intravenous Fluid Transfer Drug Devices Market
27. Russia Intravenous Fluid Transfer Drug Devices Market
28. North America Intravenous Fluid Transfer Drug Devices Market
29. USA Intravenous Fluid Transfer Drug Devices Market
30. Canada Intravenous Fluid Transfer Drug Devices Market
31. South America Intravenous Fluid Transfer Drug Devices Market
32. Brazil Intravenous Fluid Transfer Drug Devices Market
33. Middle East Intravenous Fluid Transfer Drug Devices Market
34. Africa Intravenous Fluid Transfer Drug Devices Market
36. Intravenous Fluid Transfer Drug Devices Market Competitive Landscape and Company Profiles
37. Intravenous Fluid Transfer Drug Devices Market Other Major and Innovative Companies
40. Intravenous Fluid Transfer Drug Devices Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Intravenous Fluid Transfer Drug Devices Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses intravenous fluid transfer drug devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for intravenous fluid transfer drug devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The intravenous fluid transfer drug devices market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Type: Infusion Bags; Infusion Devices; Other Types2) By Application: Autoimmune Diseases; Blood Disorders; Cardiovascular Disorders; Neurology; Oncology; Other Applications
3) By End-Use Sector: Hospitals; Specialized Clinics; Other End-Use Sectors
Subsegments:
1) By Infusion Bags: PVC Infusion Bags; Non-PVC Infusion Bags; Pre-Filled Infusion Bags; Multi-Chamber Infusion Bags; IV Fluid Administration Bags2) By Infusion Devices: Infusion Pumps; Syringe Pumps; Ambulatory Infusion Pumps; Gravity Infusion Devices; Smart Infusion Devices
3) By Other Types: IV Sets And Accessories; IV Catheters; Needleless Connectors; Flow Regulators; Pressure Infusion Devices
Companies Mentioned: Cardinal Health Inc.; Medtronic plc; Becton Dickinson and Company; Baxter International Inc.; B Braun Holding GmbH Co KG; Fresenius Kabi AG; Nipro Corporation; West Pharmaceutical Services Inc.; ICU Medical Inc.; Merit Medical Systems Inc.; Vygon SAS; AngioDynamics Inc.; Elcam Medical Inc.; InfuSystem Holdings Inc.; CODAN US Corporation; Arcomed AG; Terumo Corporation; Smiths Medical; IRadimed Corporation; Micrel Medical Devices SA; Boston Scientific Corporation; AdvaCare Pharma; Eitan Medical; Ypsomed Holding AG
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Intravenous Fluid Transfer Drug Devices market report include:- Cardinal Health Inc.
- Medtronic plc
- Becton Dickinson and Company
- Baxter International Inc.
- B Braun Holding GmbH Co KG
- Fresenius Kabi AG
- Nipro Corporation
- West Pharmaceutical Services Inc.
- ICU Medical Inc.
- Merit Medical Systems Inc.
- Vygon SAS
- AngioDynamics Inc.
- Elcam Medical Inc.
- InfuSystem Holdings Inc.
- CODAN US Corporation
- Arcomed AG
- Terumo Corporation
- Smiths Medical
- IRadimed Corporation
- Micrel Medical Devices SA
- Boston Scientific Corporation
- AdvaCare Pharma
- Eitan Medical
- Ypsomed Holding AG
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 8.35 Billion |
| Forecasted Market Value ( USD | $ 10.55 Billion |
| Compound Annual Growth Rate | 6.0% |
| Regions Covered | Global |
| No. of Companies Mentioned | 25 |
